GLP-1 Drugs Associated With Smell and Taste Disruptions | ClinicLens

People who use glucagon-like peptide-1 (GLP-1) medications may have an increased risk of smell and taste disturbances, new research suggests.

Medical Literature · Updated 2026-08-10

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.